Canopy Growth Corp

CGC

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
CGC
CIK0001737927
SIC2833
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupMedicinal Chemicals

Contact

Address1 HERSHEY DRIVE, SMITH FALLS, A6, K7A0A8
Website canopygrowth.com
Phone855-558-9333
CEODavid E. Klein
Employees3,150

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$187.07 million
Pre-Tax Income$-415.19 million
Net Income$-415.96 million
Net Income to Common$-415.96 million
EPS$-3.87
View All
Balance Sheet
Cash$79.15 million
Assets$638.22 million
Liabilities$299.39 million
Common Equity$338.84 million
Liabilities & Equity$638.22 million
View All
Cash Flow Statement
Calculations
NOPAT$-57.03 million
EBITDA$-385.20 million
Price to EarningsN/A
Price to Book$0.66
ROE-117.42%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Article Link

Cannabis Lighting Market Report 2025-2030 | Share Analysis, Industry Trends & Statistics, Growth Forecasts - Pfizer Ventures into Cannabis with $6.7 Billion Deal, Boosting Industry Growth

The Cannabis Lighting Market is set to grow at a CAGR of 7.6% during the forecast period, driven by rising medical cannabis use and cultivation. Key players like Pfizer are entering the market. LED lights are a major trend due to energy efficiency, with North America leading. New launches by companies like OSRAM enhance growth.Dublin, July 01, 2025 (GLOBE NEWSWIRE) -- The "Cannabis Lighting - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)" has been added to R

Article Link

Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors

Canopy Growth Corporation (CGC) closed at $1.22 in the latest trading session, marking a -1.61% move from the prior day.

Article Link

Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Article Link

Pot Stock Euphoria Vanishes as US Legalization Remains Elusive

(Bloomberg) -- The stock market’s marijuana boom is over. And for the once high-flying cannabis industry, a euphoric dream of never-ending growth has turned into a survival nightmare as it navigates through the bust. Most Read from BloombergNext Stop: Rancho Cucamonga!Where Public Transit Systems Are Bouncing Back Around the WorldTrump Said He Fired the National Portrait Gallery Director. She’s Still There.US Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents WarnSenator Calls for Clo

Article Link